Don Milligan

2.1k citations

26 papers · 1.1k indexed · h-index 13

Hematology top 1%
- Acute Myeloid Leukemia Research 6
- Hematopoietic Stem Cell Transplantation 5
Genetics top 2%
- Chronic Lymphocytic Leukemia Research 9
Pathology and Forensic Medicine top 5%
- Lymphoma Diagnosis and Treatment 9
Immunology top 10%
- Immunodeficiency and Autoimmune Disorders 4
- Immune Cell Function and Interaction 2
Oncology top 10%
Public Health, Environmental and Occupational Health
- Acute Lymphoblastic Leukemia research 4
Molecular Biology
- Retinoids in leukemia and cellular processes 3

Co-authors: David C. Linch Stephen Mackinnon Anne Parker Robert K. Hills Claire Dearden Nigel H. Russell Alan K. Burnett Kirsty Thomson
Cited by: Hematology Genetics Pathology and Forensic Medicine
Journals: Blood (13 papers)Journal of Clinical Oncology (3 papers)British Journal of Haematology (2 papers)
Partner nations: United Kingdom United States Denmark

In The Last Decade

Don Milligan

26 papers receiving 1.1k citations

Peers

Countries citing papers authored by Don Milligan

Since Specialization

Citations

This map shows the geographic impact of Don Milligan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Don Milligan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Don Milligan more than expected).

Fields of papers citing papers by Don Milligan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Don Milligan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Don Milligan. The network helps show where Don Milligan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Don Milligan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Don Milligan Line = papers co-authored together Don Milligan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial The Lancet Oncology ·Richard A. Anderson,Erica Klevay,Amy A. Kirkwood,Pip Patrick,Gord Christmas,Laura Clifton‐Hadley,Thomas A. Roberts,Chris Hatton,Nagesh Kalakonda,Don Milligan,Pam McKay,Clare Rowntree,Denny Adri Tarumingi,Peter Johnson	2018	52
2	Vosaroxin and vosaroxin plus low-dose Ara-C (LDAC) vs low-dose Ara-C alone in older patients with acute myeloid leukemia Blood ·Mike Dennis,Nigel H. Russell,Robert K. Hills,Claire Hemmaway,Nicki Panoskaltsis,Mary‐Frances McMullin,Lars Kjeldsen,Helen Dignum,Ian F. Thomas,Richard E. Clark,Don Milligan,Alan K. Burnett	2015	39
3	A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients Blood ·Alan K. Burnett,Nigel H. Russell,Robert K. Hills,Jonathan Kell,Jamie Cavenagh,Lars Kjeldsen,Mary‐Frances McMullin,Paul Cahalin,Mike Dennis,Lone Smidstrup Friis,Ian F. Thomas,Don Milligan,Richard E. Clark	2015	194
4	Reduced Intensity Allogeneic Stem Cell Transplant for Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm Hematology Reports ·Anand Lokare,Emmanouil Nikolousis,Neil Phillips,Marco Andr,Richard Lovell,Bhuvan Kishore,Don Milligan,Shankara Paneesha	2014	4
5	Inclusion of chemotherapy in addition to anthracycline in the treatment of acute promyelocytic leukaemia does not improve outcomes: results of the MRC AML15 trial Leukemia ·Alan K. Burnett,Robert K. Hills,David Grimwade,Jelena Jovanović,J Craig,M. F. McMullin,Jonathan Kell,Keith Wheatley,J. A. Liu Yin,Ann Hunter,Don Milligan,Nigel H. Russell	2012	53
6	Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia British Journal of Haematology ·David Oscier,Claire Dearden,Efrem Eren,Chris Fegan,George Follows,Peter Hillmen,Tim Illidge,Estella Matutes,Don Milligan,Andrew R. Pettitt,Anna Schuh,J. Z. Wimperis	2012	114
7	A randomized phase II trial of fludarabine, cyclophosphamide and mitoxantrone (FCM) with or without rituximab in previously treated chronic lymphocytic leukaemia British Journal of Haematology ·Peter Hillmen,D. Cohen,Kim Cocks,Andrew R. Pettitt,Rowallan,Andy C. Rawstron,Daniel B. Kennedy,Chris Fegan,Don Milligan,John Radford,Jane Mercieca,Claire Dearden,Kabese Kayigamba,M. B. Stevenson,Julia Brown,Agustina Suparyti,Abraham Varghese,Christopher Pocock,(unknown)	2011	32
8	HUMAN LEUKOCYTE ANTIGEN MATCHING AND CONDITIONING IMPACT ON LONG-TERM TRANSPLANT OUTCOME AFTER ALLOGENEIC HSCT FOR CHRONIC LYMPHOCYTIC LEUKEMIA Haematologica ·Mauricette Michallet,Mohamed Sobh,Don Milligan,Stéphane Morisset,Lidwina Topo,Vladimír Koza,Tapani Ruutu,NH Russell,Leo F. Verdonck,Nathalie Dhédin,Antonı́n Vı́tek,M. Boogaerts,Lars L. Vindeløv,Jürgen Finke,Valérie Dubois,Anja van Biezen,R. Brand,Peter Dreger	2010	1
9	T-Cell–Depleted Reduced-Intensity Transplantation Followed by Donor Leukocyte Infusions to Promote Graft-Versus-Lymphoma Activity Results in Excellent Long-Term Survival in Patients With Multiply Relapsed Follicular Lymphoma Journal of Clinical Oncology ·Kirsty Thomson,Emma Morris,Don Milligan,Anne Parker,Ann E. Hunter,Gordon Cook,Adrian Bloor,Fiona Clark,Majid Kazmi,David C. Linch,Ronjon Chakraverty,Karl S. Peggs,Stephen Mackinnon	2010	103
10	In vivo T-cell depletion in allogeneic haematopoietic cell transplantation for chronic lymphocytic leukaemia: a retrospective EBMT analysis Bone Marrow Transplantation ·Johannes Schetelig,Don Milligan,D Niederwieser,Liisa Volin,Johan Maertens,رابح ماشه,Aloïs Gratwohl,Martin Bornhaeuser,Michel van Gelder,Anja van Biezen,R. Brand,T de Witte,Peter Dreger	2009	2
11	The prognostic significance of a positive direct antiglobulin test in chronic lymphocytic leukemia: a beneficial effect of the combination of fludarabine and cyclophosphamide on the incidence of hemolytic anemia Blood ·Claire Dearden,Rachel Wade,Monica Else,Sue Richards,Don Milligan,Terry J. Hamblin,Daniel Catovsky	2007	92
12	Idarubicin and ATRA Is as Effective as MRC Chemotherapy in Patients with Acute Promyelocytic Leukaemia with Lower Toxicity and Resource Usage: Preliminary Results of the MRC AML15 Trial. Blood ·Alan K. Burnett,Robert K. Hills,David Grimwade,Anthony H. Goldstone,Ann Hunter,Don Milligan,Archie Prentice,Nigel H. Russell,Keith Wheatley	2007	14
13	NCRI CLL201 Trial: A Randomized Phase II Trial of Fludarabine, Cyclophosphamide and Mitoxantrone (FCM) with or without Rituximab in Previously Treated CLL. Blood ·Peter Hillmen,Christopher Pocock,D. Cohen,Kim Cocks,Rowallan,Andy C. Rawstron,Daniel B. Kennedy,Chris Fegan,Don Milligan,Claire Dearden,M. B. Stevenson,Brett Reynolds,Andrew R. Pettitt	2007	8
14	The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial. Blood ·Claire Dearden,Rachel Wade,Monica Else,Sue Richards,Don Milligan,Terry J. Hamblin,Daniel Catovsky	2007	1
15	JAK2 V617F Mutation Identifies a Biologically Distinct Subtype of Essential Thrombocythemia Which Resembles Polycythemia Vera. Blood ·Anthony R. Green,Peter J. Campbell,Linda M. Scott,Georgina Buck,Keith Wheatley,Clare East,Joanne Marsden,Ana-Elena Villafranca Iturre,Elaine Boyd,Anthony J. Bench,Mike Scott,George S. Vassiliou,Don Milligan,Steve Smith,Wendy N. Erber,D. Bareford,Bridget S. Wilkins,John F. Reilly,Claire Harrison	2005	6
16	Attempts to modulate chemoresistance in older patients with AML using PSC-833 - Results of the LRF AML14 trial Blood ·Alan K. Burnett,Robert K. Hills,A H Goldstone,A. G. Prentice,Don Milligan,Monica Pallis,Nigel H. Russell,Juan Antono Carrllo,Keith Wheatley	2003	4
17	Modeling Costs and Cost-Effectiveness of Different CMV Management Strategies in Liver Transplant Recipients as a Support for Current and Future Decision Making Value in Health ·Lieven Annemans,K Moeremans,David Mutimer,H. Schneeberger,Don Milligan,Maria Kubin	2002	8
18	Abstracts of the 2001 Annual IDSA Meeting Clinical Infectious Diseases ·Don Milligan,farahnaz ahang,Andrea Tramarin,Andrew J. Ullmann,H. Wandt,Boris Kriger,Anatoly Peresunko,ピヤトーンケウワッタナ,Jia Jing-hua,Richard J. Nowak,Rajwan Jawad Hassan,M Irone,Gerlinde Egerer,T. McCann,Jonathan Sandoe,英明新川	2001	2
19	Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. PubMed ·Nina Salooja,R Chatterjee,Andrew McMillan,G. Mestres,Adrian C. Newland,Don Milligan,I M Franklin,R. M. Hutchinson,D C Linch,A. H. Goldstone	1994	35
20	Successful treatment of acute myeloid leukemia beyond first remission with autologous bone marrow transplantation using busulfan/cyclophosphamide and unpurged marrow: the British autograft group experience. Journal of Clinical Oncology ·ピヤトーンケウワッタナ,A. H. Goldstone,Andrew McMillan,R Powles,A.T. Marseille,H. G. Prentice,C. D. L. Reid,R. E. Marcus,A.J. Bell,Don Milligan	1991	35

About Don Milligan

Don Milligan is a scholar working on Hematology, Genetics, Pathology and Forensic Medicine, Transplantation and Immunology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (9 papers), Acute Myeloid Leukemia Research (6 papers), Hematopoietic Stem Cell Transplantation (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Retinoids in leukemia and cellular processes (3 papers) and Immune Cell Function and Interaction (2 papers). The work is most often cited by research in Hematology (637 citations), Genetics (384 citations), Pathology and Forensic Medicine (369 citations), Immunology (312 citations) and Oncology (327 citations). Don Milligan has collaborated with scholars based in United Kingdom, United States and Denmark. Frequent co-authors include David C. Linch, Stephen Mackinnon, Anne Parker, Robert K. Hills, Claire Dearden, Nigel H. Russell, Alan K. Burnett, Kirsty Thomson, Karl S. Peggs and Emma Morris. Their work appears in journals such as Blood, Journal of Clinical Oncology, British Journal of Haematology, Clinical Infectious Diseases and Bone Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact